Nanoplatform-mediated calcium overload for cancer therapy

Area of Science:

• Biochemistry
• Cell Biology
• Nanomedicine

Background:

• Mitochondria are crucial for cellular energy and signaling.
• Calcium (Ca²⁺) homeostasis is vital for mitochondrial function, particularly in rapidly metabolizing cancer cells.
• Ca²⁺ overload can selectively trigger apoptosis in cancer cells, presenting a theranostic approach.

Purpose of the Study:

• To review nanoplatform designs for achieving Ca²⁺ overload in cancer therapy.
• To highlight strategies for both monotherapy and combination therapy using Ca²⁺ overload.
• To discuss current limitations and future prospects for Ca²⁺ overload-based cancer treatments.

Main Methods:

• Literature review of nanoplatforms and Ca²⁺ overload strategies.
• Analysis of theranostic models for cancer suppression.
• Examination of mitochondrial apoptosis pathways activated by Ca²⁺ overload.

Main Results:

• Nanoplatforms are being developed to integrate Ca²⁺ overload functionalities for targeted cancer therapy.
• Ca²⁺ overload via nanoplatforms shows promise for monotherapy and combination treatments.
• Successful integration of Ca²⁺ overload mechanisms into nanomedicine is challenging but significant.

Conclusions:

• Nanoplatforms offer a promising avenue for exploiting Ca²⁺ overload as a cancer theranostic strategy.
• Further research is needed to overcome scientific restrictions and fully realize the potential of Ca²⁺ overload in cancer therapy.
• Future exploitation directions include refining nanoplatform design and understanding Ca²⁺-mediated signaling in cancer.